Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
Nuklearmedizin. Nuclear Medicine|December 1, 1996
Non-uniform attenuation correction for myocardial SPET using two Gd-153 line sourcesR Kluge, A Seese, B Sattler, et al.Drug Design and Discovery|November 1, 1995
Molecular simulation of 8-styrylxanthinesP P Mager, R Reinhardt, M Richter, et al.European Journal of Nuclear Medicine|September 8, 1997
Attenuation correction by simultaneous emission-transmission myocardial single-photon emission tomography using a technetium-99m-labelled radiotracer: impact on diagnostic accuracyR Kluge, B Sattler, A Seese, et al.Der Nervenarzt|June 10, 2000
[Diminution of hand writing area and D2-dopamine receptor blockade. Results from treatment with typical and atypical neuroleptics]U Künstler, K Hohdorf, R Regenthal, et al.Drug Design and Discovery|July 1, 1992
QSAR, diagnostic statistics and molecular modelling of 1,4-dihydropyridine calcium antagonists: a difficult road aheadP P Mager, R A Coburn, A J Solo, et al.Zentralblatt Fur Gynakologie|May 24, 2001
[18F-FDG positron-emission-tomography in cervical carcinoma: preliminary findings]G Kühnel, L C Horn, U Fischer, et al.Nuklearmedizin. Nuclear Medicine|May 13, 1999
Improvement of brain SPECT by stabilization of Tc-99m-HMPAO with methylene blue or cobalt chloride. Comparison with Tc-99m-ECDH Barthel, I Kämpfer, A Seese, et al.European Journal of Nuclear Medicine|August 1, 1996
Changes in local cerebral blood flow by neuroactivation and vasoactivation in patients with impaired cognitive functionW H Knapp, C Dannenberg, B Marschall, et al.Hepatology (Baltimore, Md.)|May 9, 2001
Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancerR Kluge, F Schmidt, K Caca, et al.Nuklearmedizin. Nuclear Medicine|August 1, 1997
[Striatal uptake of I-123-beta-CIT and I-123-IBZM in patients with extrapyramidal symptoms]S Bettin, I Kämpfer, A Seese, et al.Pageof 6